Hildegarde Naughton (Galway West, Fine Gael) | Oireachtas source

I realise the importance of having these services in place. I will raise the Senator's concerns directly with the Minister. While it is not possible to give a definitive timeline for the passage of the AHR Bill through the Houses, this matter is a priority for the Government.

Regarding current supports for those undertaking AHR treatment, a defined list of fertility medicines needed for such treatment is covered under the high-tech arrangement administered by the HSE. I am aware that such schemes can have a material impact on the cost of AHR treatment for individuals who avail of them. In addition, other supports are available to patients who access treatment privately. They may claim tax relief on the costs involved under the tax relief for medical expenses scheme. Nevertheless, the Department is committed to establishing a proper regulatory framework for AHR and then to completing the roll-out of the model of care for infertility.Ultimately, we have two main end goals. First, in respect of the legislation, we aim to ensure that assisted human reproduction practices and related areas of research are conducted in a more consistent and standardised way and with the necessary oversight. Second, through the full implementation of model of care for infertility, our aim is make certain patients receive care at the appropriate level of clinical intervention and that those requiring, and eligible for, advanced treatment are able to access this through the public health system.

I thank Senator Ahearn for raising this really important issue and assure him that I will raise it directly with the Minister.